Healthcare Analysts discuss emerging treatment options for High-Rick Non-Muscle Invasive Bladder Cancer (NMIBC) (relevant companies ENGN CGON JNJ IBRX TARA) on an Analyst/Industry conference call to be held on September 10.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENGN: